API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospace.com/article/zealand-sets-the-stage-for-dasiglucagon-nda-following-fourth-straight-phase-iii-win-in-severe-hypoglycemia/?s=95
https://endpts.com/hypoglycemia-epipen-clears-phase-iii-hurtles-toward-fda-decision/
https://www.pharmacompass.com/pdf/news/novo-nordisk-recalls-glucagen-hypokit-in-us-after-error-at-syringe-supplier-1473845223.pdf
http://www.prnewswire.com/news-releases/novo-nordisk-inc-issues-voluntary-nationwide-recall-of-six-batches-of-glucagen-hypokit-glucagon-rdna-origin-for-injection-due-to-detached-needles-on-the-syringe-in-the-kit-300324995.html